Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients.
about
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Prostate Cancer: A Systematic Review and Meta-analysisPrognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical reviewPlatelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapyPretreatment Neutrophil-to-Lymphocyte Ratio: A Predictor of Advanced Prostate Cancer and Biochemical Recurrence in Patients Receiving Radical Prostatectomy.Evaluation of neutrophil-to-lymphocyte ratio prior to prostate biopsy to predict biopsy histology: Results of 1836 patients.Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients.The prognostic significance of postoperative neutrophil-to-lymphocyte ratio after radical prostatectomy for localized prostate cancer.Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy in localized prostate cancer.A Combination of Testosterone and White Blood Cell Count as a Predictive Factor of Overall Survival in Localized Prostate Cancer.High preoperative neutrophil-lymphocyte ratio predicts biochemical recurrence in patients with localized prostate cancer after radical prostatectomy.Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination.Peripheral monocyte count: an independent diagnostic and prognostic biomarker for prostate cancer - a large Chinese cohort studyAlbumin and Fibrinogen Combined Prognostic Grade Predicts Prognosis of Patients with Prostate Cancer.Clinical implications of pretreatment inflammatory biomarkers as independent prognostic indicators in prostate cancer.Combined analysis of the pre- and postoperative neutrophil-lymphocyte ratio predicts the outcomes of patients with gastric cancer.The dynamic change of neutrophil to lymphocyte ratio can predict clinical outcome in stage I-III colon cancer.
P2860
Q26773406-5C9381DF-0696-45E2-88F9-03D4E2B9E131Q28073742-42DDF089-8FB8-4D27-AA0E-5AAFED966D1BQ36028749-648590B4-4BC0-40DF-BCE1-4E1EB739CE31Q36195647-34477467-D569-4A27-B088-DCBE5BBA552CQ36264770-B1B0C9DF-0792-41C1-94C3-EFAB029BA2F1Q38623275-5982EF94-FDD2-459A-939F-EF915EE7B729Q39041165-A83E2080-C0B5-4BA4-93BE-E33B3EF2B85FQ39651226-5BECE3C9-E08E-47C7-B68A-5A7564D0F084Q40121315-8115EF84-3A29-4789-BA62-A7DF0859C422Q40960782-6102434B-9E5E-46CB-894E-F57B24F9108FQ41041538-BB809371-2582-467F-9EC4-EB4E7E6FC8EEQ41486852-709F61C0-224D-432A-B507-F16754258F58Q47162057-BE526FF1-EFA2-4FBC-8792-EC43B63088BBQ48292148-D6406C4C-3938-4551-B7FF-288D81F05C83Q50060426-9E1DA423-7858-424F-8F08-A8E87A37080BQ55413490-3B2AEEF9-78DA-43F0-BA34-406404D5BC2B
P2860
Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Validation of the neutrophil-t ...... pean prostate cancer patients.
@en
Validation of the neutrophil-t ...... pean prostate cancer patients.
@nl
type
label
Validation of the neutrophil-t ...... pean prostate cancer patients.
@en
Validation of the neutrophil-t ...... pean prostate cancer patients.
@nl
prefLabel
Validation of the neutrophil-t ...... pean prostate cancer patients.
@en
Validation of the neutrophil-t ...... pean prostate cancer patients.
@nl
P2093
P2860
P1476
Validation of the neutrophil-t ...... pean prostate cancer patients.
@en
P2093
Armin Gerger
Eva-Maria Thurner
Martin Pichler
Sabine Krenn-Pilko
Tanja Langsenlehner
Tatjana Stojakovic
Uwe Langsenlehner
P2860
P2888
P304
P356
10.1007/S00345-015-1494-7
P577
2015-01-24T00:00:00Z